# Exai Bio Inc. — Form D

Exai Bio Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-11. The offering totals $71.5M, of which $70.6M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-10-11
- Form: D
- Accession: 0001887123-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $71.5M
- Amount sold: $70.6M
- Remaining: $808K
- Investors: 21
- Date of first sale: 2021-09-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-461365

## Issuer

- Name: Exai Bio Inc.
- CIK: 0001887123
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 3350 W. BAYSHORE ROAD, PALO ALTO, CA, 94303
- Phone: 000-000-0000

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Patrick A Arensdorf | Director | Palo Alto, CA |
| Hani A Goodarzi | Director | Palo Alto, CA |
| Alexander A Parker | Director | New York, NY |
| Michael A Pellini | Director | Los Altos, CA |
| Patrick A Arensdorf | Executive Officer | Palo Alto, CA |

## More

- [CIK 1887123 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1887123&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001887123-22-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.